Peripheral leukocyte counts and outcomes after intracerebral hemorrhage
© Agnihotri et al; licensee BioMed Central Ltd. 2011
Received: 11 July 2011
Accepted: 16 November 2011
Published: 16 November 2011
Intracerebral hemorrhage (ICH) is a devastating disease that carries a 30 day mortality of approximately 45%. Only 20% of survivors return to independent function at 6 months. The role of inflammation in the pathophysiology of ICH is increasingly recognized. Several clinical studies have demonstrated an association between inflammatory markers and outcomes after ICH; however the relationship between serum biomarkers and functional outcomes amongst survivors has not been previously evaluated. Activation of the inflammatory response as measured by change in peripheral leukocyte count was examined and assessment of mortality and functional outcomes after ICH was determined.
Patients with spontaneous ICH admitted to a tertiary care center between January 2005 and April 2010 were included. The change in leukocyte count was measured as the difference between the maximum leukocyte count in the first 72 hours and the leukocyte count on admission. Mortality was the primary outcome. Secondary outcomes were mortality at 1 year, discharge disposition and the modified Barthel index (MBI) at 3 months compared to pre-admission MBI. 423 cases were included. The in-hospital mortality was 30.4%. The change in leukocyte count predicted worse discharge disposition (OR = 1.258, p = 0.009). The change in leukocyte count was also significantly correlated with a decline in the MBI at 3 months. These relationships remained even after removal of all patients with evidence of infection.
Greater changes in leukocyte count over the first 72 hours after admission predicted both worse short term and long term functional outcomes after ICH.
Cerebrovascular disease is the leading cause of morbidity and mortality in the United States. Intracerebral hemorrhage (ICH) is a devastating subtype of stroke, which has worse outcomes than ischemic stroke, is increasing in prevalence, and has a 30 day mortality of 40-50% [1, 2]. Only 20% of patients with ICH return to independent function at 6 months [2, 3]. Despite advances in management, the mortality of ICH has not changed significantly over time . The role of inflammation in the pathophysiology of ICH is now increasingly recognized. In animal models, a robust inflammatory response is triggered by the entry of blood into the brain parenchyma  with a subsequent infiltration of peripheral leukocytes, activation of microglia and release of cytokines [6, 7]. Autopsies in both animals  and humans  with ICH demonstrate leukocytic infiltration usually within first 3 days and inflammatory changes in the penumbra of the hemorrhage. Few clinical studies have demonstrated association between the inflammatory markers and outcomes of ICH in terms of mortality [10, 11]. None of these studies evaluated functional or long term outcomes.
We evaluated the relationship between activation of the inflammatory response as measured by change in peripheral leukocyte count, and mortality and functional outcomes after ICH.
This is a retrospective analysis from the existing stroke database at Hartford Hospital, a tertiary care hospital with a primary stroke center in Hartford, CT, USA. The study was reviewed and approved by the Hartford hospital IRB. We included patients with spontaneous ICH from Jan 2005 to April 2010. We excluded subarachnoid hemorrhages, hemorrhages secondary to trauma, malformations, coagulopathy, and tumors as well as patients with leukemia. Baseline characteristics including age, gender, blood pressure, infection within first 72 hours, NIH on admission and ICH score were obtained. The maximum leukocyte counts in the first 72 hours as well as on admission were recorded. The difference between the two values was calculated to obtain the independent variable of change in leukocyte count, which was measured as a continuous variable. The outcomes were measured as in hospital mortality, 12 month mortality, discharge disposition, and the loss on MBI points calculated as a difference between a pre stroke MBI and a MBI at 3 months. Disposition was dichotomized as discharge to worse vs. same or better based on the pre-admit residence. The loss of MBI points was measured as a continuous variable. Data on infection within first 72 hours including that on admission was also collected. Patients with clinical signs and symptoms of infection, including fever, raised peripheral WBC, worsening sensorium, cough, abdominal pain, or diarrhea underwent an infectious work up. The initial work up included urinalysis, chest x-ray, blood cultures, stool for Clostridium difficile. If these were abnormal, appropriate cultures were obtained. Those cultures that were identified as bacterial colonization, were excluded from our analysis. Further subgroup analysis after removal of patients with documented infections was also performed. SPSS was used to perform statistical analyses including t-test, linear correlation, and logistic regression. A p value of < 0.05 was considered significant.
Demographics and Leukocyte data
ICH volume (in cubic centimeters)
NIH on admission
First leukocyte count
Maximum leukocyte count in the first 72 hours
Change in leukocyte count from admission to 72 hours
Infection within 72 hours
Lung infection within 72 hours
Urine infection within 72 hours
Change in Leukocyte counts: admission to maximum in 72 hours
1 year mortality
MBI change @ 3 months
MBI change @ 12 months
Our results demonstrate that peripheral activation of inflammation predicts outcomes after ICH. Prior clinical studies have examined temperature, admission leukocyte count and C-reactive protein as measures of inflammation and have demonstrated their association with ICH volume and mortality [10, 11]. Previous studies have documented that higher peripheral leukocyte counts are associated with early neurologic deterioration but were not independently associated with functional outcomes as measured by modified rankin scale at 30 days . One recent study found that although a higher white blood cell count was associated with increased mortality in ICH patients, but this did not increase the risk of death independently of other indicators of ICH severity . In contrast to our work, no association was seen between median leukocyte count and functional outcome at 30 days . This may be due to the two-fold larger sample size and the use of change in WBC over 72 hours rather than use of the median WBC count in this study. The robustness of our data is evident in the fact that in the subgroup analysis where infections are excluded, the association between change in leukocyte count and the discharge disposition remains significant.
Peripheral leukocytes are a marker of the response of the immune system and reflect the activation of the inflammatory cascade following a spontaneous ICH . This is an easily and widely available biomarker. The change in the leukocyte count over 72 hours may better reflect the amount of inflammatory response mounted in response to the ICH compared to a single value. The use of this variable is advantageous as it reduces the impact of premorbid conditions that affect the leukocyte count, and may more accurately reflect the amount of neuroinflammation as it remained predictive even when adjusted for infections on admission as well as those that developed within 72 hours of presentation.
In our study, the peripheral leukocyte count independently predicts poor functional outcomes in terms of discharge disposition and the loss of points on the MBI at 3 months. This suggests that activation of peripheral immune system may enhance injury after ICH, consistent with emerging experimental work . We could not establish an association with mortality and it is most likely due to loss of leukocyte count data on patients who were made hospice early on in the care. Similarly, we could not establish a trend for MBI at 12 months largely due to missing information which is a limitation in this study. However, the change in leukocyte count was predictive of outcome at 3 months, one of the longest outcome assessments correlated with a biomarker to date in ICH patients.
There are several limitations of this study which include the retrospective design, single center population and missing data on certain variables, especially at 12 months, largely due to the high mortality from this disease. However, this is one of the largest samples to date, and clearly demonstrated the association between the peripheral immune response and poor functional outcomes after ICH independent of infection or hemorrhage size. Treatments for ICH have focused on blood pressure management and reducing ICH volume . None of these treatments have made a significant impact on patient outcome. Mortality and morbidity have not changed in several decades, despite improvements in ICU care. This study provides further evidence for the potential of targeting neuroinflammation as a treatment modality to improve outcomes amongst ICH survivors.
To SA (Department of Neurology Resident Research Fund), AC (Hartford Hospital Small Grant Program).
- Roger VL, Go AS, Lloyd-Jones DM, Adams RJ: Heart disease and stroke statistics - 2011 update: a report from the American Heart Association. Circulation. 2011, 123 (4): e18-e209. 10.1161/CIR.0b013e3182009701.PubMed CentralView ArticlePubMedGoogle Scholar
- Van Asch CJ, Luitse MJ, Rinkel GJ: Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis. Lancet Neurol. 2010, 9 (2): 167-176. 10.1016/S1474-4422(09)70340-0.View ArticlePubMedGoogle Scholar
- Bamford J, Sandercock P, Dennis M, Burn J, Warlow C: A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project--1981-86. 2. Incidence, case fatality rates and overall outcome at one year of cerebral infarction, primary intracerebral and subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry. 1990, 53 (1): 16-22. 10.1136/jnnp.53.1.16.PubMed CentralView ArticlePubMedGoogle Scholar
- Flaherty ML, Haverbusch M, Sekar P: Long-term mortality after intracerebral hemorrhage. Neurology. 2006, 66: 1182-1186. 10.1212/01.wnl.0000208400.08722.7c.View ArticlePubMedGoogle Scholar
- Loftspring MC, Hansen C, Clark JF: A novel brain injury mechanism after intracerebral hemorrhage: the interaction between heme products and the immune system. Med Hypotheses. 2010, 74 (1): 63-66. 10.1016/j.mehy.2009.08.002.PubMed CentralView ArticlePubMedGoogle Scholar
- Xi G, Keep RF, Hoff JT: Mechanisms of brain injury after intracerebral hemorrhage. Lancet Neurol. 2006, 5 (1): 53-63. 10.1016/S1474-4422(05)70283-0.View ArticlePubMedGoogle Scholar
- Wang J, Doré S: Inflammation after intracerebral hemorrhage. J Cereb Blood Flow Metab. 2007, 27 (5): 894-908.PubMedGoogle Scholar
- Gong C, Hoff JT, Keep RF: Acute inflammatory reaction following experimental intracerebral hemorrhage in rat. Brain Res. 2000, 871 (1): 57-65. 10.1016/S0006-8993(00)02427-6.View ArticlePubMedGoogle Scholar
- Mackenzie JM, Clayton JA: Early cellular events in the penumbra of human spontaneous intracerebral hemorrhage. J Stroke Cerebrovasc Dis. 1999, 8 (1): 1-8. 10.1016/S1052-3057(99)80032-9.View ArticlePubMedGoogle Scholar
- Di Napoli M, Godoy DA, Campi V, del Valle M: C-reactive protein level measurement improves mortality prediction when added to the spontaneous intracerebral hemorrhage score. Stroke. 2011, 42 (5): 1230-1236. 10.1161/STROKEAHA.110.604983.View ArticlePubMedGoogle Scholar
- Suzuki S, Kelley RE, Dandapani BK: Acute leukocyte and temperature response in hypertensive intracerebral hemorrhage. Stroke. 1995, 26 (6): 1020-1023. 10.1161/01.STR.26.6.1020.View ArticlePubMedGoogle Scholar
- Liera R, Davalos A, Silva Y, Gil-Peralta A, Tejada J, Garcia M, Castillo J: Early neurologic deterioration in intracerebral hemorrhage: Predictors and associated factors. Neurology. 2004, 63: 461-467.View ArticleGoogle Scholar
- Aronowski J, Zhao X: Molecular pathophysiology of cerebral hemorrhage: secondary brain injury. Stroke. 2011, 42: 1781-6. 10.1161/STROKEAHA.110.596718.PubMed CentralView ArticlePubMedGoogle Scholar
- Qureshi AI, Mendelow AD, Hanley DF: Intracerebral haemorrhage. Lancet. 2009, 373: 1632-1644. 10.1016/S0140-6736(09)60371-8.PubMed CentralView ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.